NCT03306472 2024-01-30
PIONEER
Cambridge University Hospitals NHS Foundation Trust
Phase 2 Completed
Clinical Trials
6 trialsNCT02269670 2022-04-05
Phase II Study of Everolimus Beyond Progression
Emory University
Phase 2 Terminated
NCT03024580 2019-08-15
MEGA
Instituto Nacional de Cancer, Brazil
Phase 2 Unknown
NCT00002465 2013-11-06
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00002680 2013-07-24
Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer
Yale University
Phase 2 Completed
NCT01237327 2011-05-06
Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer
Pfizer
Phase 3 Completed